Global Cord Blood (CORBF) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Global Cord Blood Corporation, currently in provisional liquidation, has encountered challenges with its extraordinary general meeting (EGM), which was adjourned and eventually dissolved due to a lack of quorum. The Joint Provisional Liquidators (JPLs) have since sought court approval for their remuneration for the period between September 2022 and September 2023. Shareholders have been notified of the developments and the court hearing for the JPLs’ remuneration approval is scheduled for July 30, 2024.
For further insights into CORBF stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money